Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int J Environ Res Public Health. 2020;17:9160. https://doi.org/10.3390/ijerph17249160.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abbas SZ, Qadir MI and Muhammad SA.Systems-level differential gene expression analysis reveals new genetic variants of oral cancer.Sci Rep.2020;10:14667. https://doi.org/10.1038/s41598-020-71346-7.

Adami GR, Tang JL and Markiewicz MR.Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.Oral Oncol.2017;69:62–7. https://doi.org/10.1016/j.oraloncology.2017.04.001.

Agarwal N and Jha AK.DNA hypermethylation of tumor suppressor genes among oral squamous cell carcinoma patients: a prominent diagnostic biomarker.Mol Biol Rep.2024;52:44. https://doi.org/10.1007/s11033-024-10144-0.

Alshahrani SA, Al-Qahtani WS, Almufareh NA, et al.Oral cancer among Khat users: finding evidence from DNA analysis of nine cancer-related gene mutations.BMC Oral Health.2021;21:626. https://doi.org/10.1186/s12903-021-01981-7.

Altamura G and Borzacchiello G.Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines.Front Vet Sci.2022;9:1040552. https://doi.org/10.3389/fvets.2022.1040552.

Aragón-Niño Í, Cuesta-Urquía C, González-Martín-Moro J, et al.HPV infection in oral cancer, our experience: prevalence, clinical implications, and current vaccination program in Spain.J Clin Exp Dent.2023;15:e584-e9. https://doi.org/10.4317/jced.60514.

Bano A, Vats R, Yadav P and Bhardwaj R.Exosomics in oral cancer diagnosis, prognosis, and therapeutics - An emergent and imperative non-invasive natural nanoparticle-based approach.Crit Rev Oncol Hematol.2022;178:103799. https://doi.org/10.1016/j.critrevonc.2022.103799.

Batistella E, Gondak R, Rivero ERC, et al.Comparison of tobacco and alcohol consumption in young and older patients with oral squamous cell carcinoma: a systematic review and meta-analysis.Clin Oral Investig.2022;26:6855–69. https://doi.org/10.1007/s00784-022-04719-z.

Biddle A, Liang X, Gammon L, et al.Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.Cancer Res.2011;71:5317–26. https://doi.org/10.1158/0008-5472.Can-11-1059.

Byrd KM, Piehl NC, Patel JH, et al. Heterogeneity within Stratified Epithelial Stem Cell Populations Maintains the Oral Mucosa in Response to Physiological Stress. Cell Stem Cell. 2019;25:814-29.e6. https://doi.org/10.1016/j.stem.2019.11.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen XJ, Zhang XQ, Liu Q, Zhang J and Zhou G.Nanotechnology: a promising method for oral cancer detection and diagnosis.J Nanobiotechnology.2018;16:52. https://doi.org/10.1186/s12951-018-0378-6.

Chen KM, Sun YW, Kawasawa YI, et al.Black Raspberry Inhibits Oral Tumors in Mice Treated with the Tobacco Smoke Constituent Dibenzo(def,p)chrysene Via Genetic and Epigenetic Alterations.Cancer Prev Res (Phila).2020;13:357–66. https://doi.org/10.1158/1940-6207.Capr-19-0496.

Chen YP, Yin JH, Li WF, et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 2020;30:1024–42. https://doi.org/10.1038/s41422-020-0374-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Feng Y, Yan F, et al. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. Front Immunol. 2022;13: 922195. https://doi.org/10.3389/fimmu.2022.922195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi SY, Shim J, Gu DE, et al.Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening.Oral Oncol.2023;146:106571. https://doi.org/10.1016/j.oraloncology.2023.106571.

Chu X, Tian W, Ning J, et al.Cancer stem cells: advances in knowledge and implications for cancer therapy.Signal Transduct Target Ther.2024;9:170. https://doi.org/10.1038/s41392-024-01851-y.

Cueva C, Silva M, Pinillos I, Bartolomé B and Moreno-Arribas MV.Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer.Nutrients.2020;12:https://doi.org/10.3390/nu12030625.

de Oliveira TB, Marta GN, de Castro JG, Kowalski LP. Induction Chemotherapy for Advanced Oral Cavity Cancer. Curr Oncol Rep. 2021;23:129. https://doi.org/10.1007/s11912-021-01119-6.

Article  PubMed  Google Scholar 

de Wit JG, Vonk J, Voskuil FJ, et al.EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial.Nat Commun.2023;14:4952. https://doi.org/10.1038/s41467-023-40324-8.

Denninghoff V, Muino A, Diaz M, et al.Mutational status of PIK3ca oncogene in oral cancer-In the new age of PI3K inhibitors.Pathol Res Pract.2020;216:152777. https://doi.org/10.1016/j.prp.2019.152777.

Dhumal SN, Choudhari SK, Patankar S, et al. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. Head Neck Pathol. 2022;16:453–65. https://doi.org/10.1007/s12105-021-01384-8.

Article  PubMed  Google Scholar 

Domingos PLB, Souza MG, Guimarães TA, et al.Hypoxia reduces the E-cadherin expression and increases OSCC cell migration regardless of the E-cadherin methylation profile.Pathol Res Pract.2017;213:496–501. https://doi.org/10.1016/j.prp.2017.02.003.

Driehuis E, Kolders S, Spelier S, et al. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy. Cancer Discov. 2019;9:852–71. https://doi.org/10.1158/2159-8290.Cd-18-1522.

Article  CAS  PubMed  Google Scholar 

D'Souza S and Addepalli V.Preventive measures in oral cancer: An overview.Biomed Pharmacother.2018;107:72–80. https://doi.org/10.1016/j.biopha.2018.07.114.

Elad S, Yarom N, Zadik Y, Kuten-Shorrer M and Sonis ST.The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.CA Cancer J Clin.2022;72:57–77. https://doi.org/10.3322/caac.21704.

Erkisa M, Karakas D, Ulukaya E. Cancer Stem Cells: Root of the Evil. Crit Rev Oncog. 2019;24:69–87. https://doi.org/10.1615/CritRevOncog.2019029512.

Article  PubMed  Google Scholar 

Fang X, Liu H, Du Y, et al.Bacillus siamensis Targeted Screening from Highly Colitis-Resistant Pigs Can Alleviate Ulcerative Colitis in Mice.Research.7:0415. https://doi.org/10.34133/research.0415.

Fang X, Liu H, Liu J, et al. Isobutyrate confers resistance to inflammatory bowel disease through host-microbiota interactions in pigs. Research. 2025;8:0673. https://doi.org/10.34133/research.0673.

Article  PubMed  PubMed Central  Google Scholar 

Feng Y, Li Q, Chen J, et al.Salivary protease spectrum biomarkers of oral cancer.Int J Oral Sci.2019;11:7. https://doi.org/10.1038/s41368-018-0032-z.

Forster M, Mendes R and Fedele S.Synthetic lethality and PARP-inhibitors in oral and head & neck cancer.Curr Pharm Des.2012;18:5431–41. https://doi.org/10.2174/138161212803307608.

Furness S, Glenny AM, Worthington HV, et al.Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.Cochrane Database Syst Rev.2011;Cd006386. https://doi.org/10.1002/14651858.CD006386.pub3.

Gabusi A, Gissi DB, Grillini S, et al.Shared epigenetic alterations between oral cancer and periodontitis: A preliminary study.Oral Dis.2023;29:2052–60. https://doi.org/10.1111/odi.14251.

Galeano Niño JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810–7. https://doi.org/10.1038/s41586-022-05435-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gan M, Liu N, Li W, et al.Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy.Mol Cancer.2024;23:273. https://doi.org/10.1186/s12943-024-02193-7.

Gangwar SK, Kumar A, Jose S, et al.Nuclear receptors in oral cancer-Emerging players in tumorigenesis.Cancer Lett.2022;536:215666. https://doi.org/10.1016/j.canlet.2022.215666.

Ghiyasimoghaddam N, Shayan N, Mirkatuli HA, et al.Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?Discov Oncol.2024;15:427. https://doi.org/10.1007/s12672-024-01308-2.

Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019;393:40–50. https://doi.org/10.1016/s0140-6736(18)32779-x.

Article  CAS  PubMed  Google Scholar 

González-Moles MA, Scully C, Ruiz-Ávila I and Plaza-Campillo JJ.The cancer stem cell hypothesis applied to oral carcinoma.Oral Oncol.2013;49:738–46. https://doi.org/10.1016/j.oraloncology.2013.04.002.

Gouvêa AF, Vargas PA, Coletta RD, Jorge J and Lopes MA.Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.J Oral Pathol Med.2010;39:447–52. https://doi.org/10.1111/j.1600-0714.2010.00889.x.

Greer SN, Metcalf JL, Wang Y and Ohh M.The updated biology of hypoxia-inducible factor.Embo j.2012;31:2448–60. https://doi.org/10.1038/emboj.2012.125.

Guo Q, Zhou Y, Xie T, et al.Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting.Genes Dis.2024;11:101043. https://doi.org/10.1016/j.gendis.2023.05.024.

Han X, Qin H, Lu Y, et al. Post-translational modifications: The potential ways for killing cancer stem cells. Heliyon. 2024;10: e34015. https://doi.org/10.1016/j.heliyon.2024.e34015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hata AN, Niederst MJ, Archibald HL, et al.Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.Nat Med.2016;22:262–9. https://doi.org/10.1038/nm.4040.

Hecht SS and Hatsukami DK.Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention.Nat Rev Cancer.2022;22:143–55. https://doi.org/10.1038/s41568-021-00423-4.

Hema KN, Smitha T, Sheethal HS and Mirnalini SA.Epigenetics in oral squamous cell carcinoma.J Oral Maxillofac Pathol.2017;21:252–9. https://doi.org/10.4103/jomfp.JOMFP_150_17.

Herremans KM, Riner AN, Cameron ME, et al. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine. Microbiome. 2022;10:93. https://doi.org/10.1186/s40168-022-01262-7.

Article  PubMed  PubMed Central  Google Scholar 

Hou Z, Wu C, Tang J, Liu S and Li L.CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.Exp Cell Res.2024;435:113935. https://doi.org/10.1016/j.yexcr.2024.113935.

Hu C, Cao Y, Li P, et al.Oleanolic Acid Induces Autophagy and Apoptosis via the AMPK-mTOR Signaling Pathway in Colon Cancer.J Oncol.2021;2021:8281718. https://doi.org/10.1155/2021/8281718.

Huang WC, Jang TH, Tung SL, et al.A novel miR-365–3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.J Exp Clin Cancer Res.2019;38:89. https://doi.org/10.1186/s13046-019-1091-5.

Huang G, Chen S, Washio J, et al. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway. Int J Mol Sci. 2023;24:1992. https://doi.org/10.3390/ijms24031992.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang TH, Huang WC, Tung SL, et al.MicroRNA-485–5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.J Biomed Sci.2022;29:42. https://doi.org/10.1186/s12929-022-00824-z.

Johansson E and Ueno H.Characterization of normal and cancer stem-like cell populations in murine lingual epithelial organoids using single-cell RNA sequencing.Sci Rep.2021;11:22329. https://doi.org/10.1038/s41598-021-01783-5.

Joseph JP, Harishankar MK, Pillai AA and Devi A.Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC.Oral Oncol.2018;80:23–32. https://doi.org/10.1016/j.oraloncology.2018.03.004.

Juric D, Rodon J, Tabernero J, et al.Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.J Clin Oncol.2018;36:1291–9. https://doi.org/10.1200/jco.2017.72.7107.

Kansy K, Hoffmann J, Bendszus M, et al.Tongue movement during articulation in magnetic resonance imaging: Findings in 20 healthy volunteers and a patient with anterior floor of the mouth squamous cell carcinoma.J Craniomaxillofac Surg.2017;45:2046–53. https://doi.org/10.1016/j.jcms.2017.09.003.

Kattimani V, Bhukya NKN, Panga GSK, Chakrabarty A and Lingamaneni P.Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review.J Maxillofac Oral Surg.2024;23:763–71. https://doi.org/10.1007/s12663-024-02251-z.

Kaur J, Jacobs R, Huang Y, Salvo N and Politis C.Salivary biomarkers for oral cancer and pre-cancer screening: a review.Clin Oral Investig.2018;22:633–40. https://doi.org/10.1007/s00784-018-2337-x.

Keshavarzi M, Darijani M, Momeni F, et al.Molecular Imaging and Oral Cancer Diagnosis and Therapy.J Cell Biochem.2017;118:3055–60. https://doi.org/10.1002/jcb.26042.

Khurshid Z, Zafar MS, Khan RS, et al. Role of Salivary Biomarkers in Oral Cancer Detection. Adv Clin Chem. 2018;86:23–70. https://doi.org/10.1016/bs.acc.2018.05.002.

Article  CAS  PubMed  Google Scholar 

Kilic SS, Campbell SR. Don’t Take the Bait, Radiate: Importance of Adjuvant Radiation Therapy for Oral Tongue Cancer. Int J Radiat Oncol Biol Phys. 2022;112:850. https://doi.org/10.1016/j.ijrobp.2021.12.158.

Article  PubMed  Google Scholar